Refeyn launches KaritroMP for rapid and reproducible characterization of large viral vectors Post author: Post published:December 4, 2023 Post category:uncategorized Refeyn, a leader in mass photometry technology, announces the launch of its macro mass photometry platform, KaritroMP. You Might Also Like Can viruses in our gut be a game changer for health? October 3, 2023 How machine learning is accelerating research in structural biology August 2, 2024 Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing January 31, 2024
Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing January 31, 2024